AzTrials
AzTrials

MeditationMEDIT-ENLIGNENCT05285488

Impact of Distance Meditation on Non-attachment to the Self and Identity Threat

A study testing "focused attention" group in people with Meditation, run by Université de Reims Champagne-Ardenne at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Meditation is widely recognized for its benefits on both physical and psychological health and more particularly on the prevention of depression relapse. However, despite a lot of literature showing its efficacy, the mechanisms of action underlying its benefits have yet to be specifically identified and empirically… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Meditation
What is being tested?
"focused attention" group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteFrance
Study dates
28 Mar 2022to 1 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • male or female
  • aged of 18 and more
  • without diagnosed psychiatric pathology
  • not practicing meditation
  • agreeing to participate in the study

Who cannot join

  • less than 18 years old

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Université de Reims-Champagne-Ardenne

    Reims, Grand Est, 51100

    Recruiting

Other trials in France

About this study

Meditation is widely recognized for its benefits on both physical and psychological health and more particularly on the prevention of depression relapse. However, despite a lot of literature showing its efficacy, the mechanisms of action underlying its benefits have yet to be specifically identified and empirically tested.

to understand these mechanisms actions, it is essential to distinguish meditative practices. Three different categories of meditation can be distinguished: "Attention Family", "Constructive Family" and "Deconstructive Family" with specific effects for each.

Read the detailed description

The aim of the study is to compare effects of two types of meditation (focused attention and contemplation) on non-attachment to the self and identity threat.

Conditions
Meditation
Being tested
"focused attention" group
Keywords
non-attachment to the self, identity threat, meditation, focused attention, contemplation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "focused attention" groupOther

    Also called "Contemplation" group

    "focused attention" group: adult subjects practicing focused attention meditation.

    "contemplation" group: adult subjects practicing contemplation meditation.

Study groups in NCT05285488
Study groupRoleWhat they receive
"focused attention" groupExperimentaladult subjects practicing focused attention meditation
Receives: Other: "focused attention" group
"Contemplation" groupActive comparatoradult subjects practicing contemplation meditation
Receives: Other: "focused attention" group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. non-attachment to the self

    Non-attachment to the self evaluated using Adult Self-transcendence Inventory (ASTI).

    ASTI is composed of 10 items. Each item is coded from 1 (totally disagree) to 7 (totally agree) by comparing how they see life at the time of the questionnaire compared to the last 5 years. The overall score ranges from 10 to 70 points.

    Measured: week 6

Secondary outcomes (1)
  1. Identity threat

    Identity threat evaluated using Cognitive Appraisal Scale (ECP). ECP is composed of 10 items. Each item is coded from 1 (totally disagree) to 6 (totally agree). The overall score ranges from 6 to 60 points

    Measured: week 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2022
  2. Study start28 Mar 2022
  3. Primary completion1 Apr 2023 (estimated)
  4. Study completion1 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05285488
Sponsor's protocol ID
2021-014-MEDIT-ENLIGNE
Acronym
MEDIT-ENLIGNE
Status last verified
Apr 2022
First submitted
8 Mar 2022
Last updated
27 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing "focused attention" group in people with Meditation, run by Université de Reims Champagne-Ardenne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Coralie BARBE, MD (0326918822 ext. +33, currs@univ-reims.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

non-attachment to the self (time frame: week 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2022; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in